Dare Bioscience, Inc. SEC filings DARE
Dare Bioscience, Inc. has 777 filings in SEC EDGAR's recent list, going back to May 29, 2007. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 27, 2026 | — |
| DEF 14A | Proxy statement | Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 2, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2026 | Oct 1, 2026 |
| PRE 14A | Preliminary proxy statement | Sep 23, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 11, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| 424B3 | Prospectus | Sep 4, 2026 | — |
| EFFECT | Filing | Sep 3, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 28, 2026 | — |
| S-1 | Registration statement | Aug 26, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 24, 2026 | — |
| D | Filing | Aug 20, 2026 | — |
| 253G2 | Filing | Aug 19, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 17, 2026 | Aug 14, 2026 |
| 424B5 | Prospectus supplement | Aug 17, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 24, 2026 | Jul 24, 2026 |
| 253G2 | Filing | Jul 17, 2026 | — |
| 8-K |
Current report
Listing notice
|
Jul 17, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 13, 2026 | Jul 13, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| S-8 | Employee stock plan registration | Jun 23, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 11, 2026 |
| DEFA14A | Additional proxy material | Jun 1, 2026 | — |
| DEFA14A | Additional proxy material | Jun 1, 2026 | — |
| 8-K |
Current report
Unregistered share sale
|
May 18, 2026 | May 14, 2026 |
| 253G2 | Filing | May 15, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Unregistered share sale
|
May 7, 2026 | May 1, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 22, 2026 | Apr 22, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Apr 20, 2026 | Apr 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 17, 2026 | Apr 16, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Apr 13, 2026 | Apr 10, 2026 |
| QUALIF | Filing | Apr 1, 2026 | — |
| 1-A POS | Filing | Mar 30, 2026 | — |
| 253G2 | Filing | Mar 30, 2026 | — |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Mar 17, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Mar 9, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jan 29, 2026 | Jan 23, 2026 |
| 253G1 | Filing | Jan 7, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2026 | Jan 6, 2026 |
| QUALIF | Filing | Jan 5, 2026 | — |
| 1-A/A | Filing | Dec 29, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 23, 2025 | — |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Dec 1, 2025 | Nov 26, 2025 |
| 1-A | Filing | Nov 25, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 6, 2025 | — |
| 4 | Insider transaction | Sep 4, 2025 | Sep 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2025 | Sep 2, 2025 |
| S-8 | Employee stock plan registration | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Other events
|
Jul 25, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Other events
|
Jul 21, 2025 | Jul 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 14, 2025 | Jul 14, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 9, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 9, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 9, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 9, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 9, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Other events
|
Jun 25, 2025 | Jun 25, 2025 |
| DEFA14A | Additional proxy material | Jun 12, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 9, 2025 | Jun 9, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 24, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 24, 2025 | — |
| DEF 14A | Proxy statement | Apr 24, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Other events
|
Apr 11, 2025 | Apr 11, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 14, 2025 | Feb 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 10, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| EFFECT | Filing | Nov 26, 2024 | — |
| 424B3 | Prospectus | Nov 26, 2024 | — |
| D | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 22, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2024 | — |
| S-1 | Registration statement | Nov 15, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 25, 2024 | Oct 25, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 23, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 21, 2024 | Oct 21, 2024 |
| UPLOAD | Letter from the SEC | Oct 8, 2024 | — |
| CORRESP | Letter to the SEC | Sep 10, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2024 | — |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 19, 2024 | Jul 18, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jun 27, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 5, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| EFFECT | Filing | May 10, 2024 | — |
| 424B5 | Prospectus supplement | May 10, 2024 | — |
| CORRESP | Letter to the SEC | May 8, 2024 | — |
| EFFECT | Filing | May 1, 2024 | — |
| 424B3 | Prospectus | May 1, 2024 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Regulation FD disclosure
|
Apr 30, 2024 | Apr 29, 2024 |
| CORRESP | Letter to the SEC | Apr 29, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 5, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2024 | Jun 5, 2024 |
| UPLOAD | Letter from the SEC | Apr 3, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| 424B5 | Prospectus supplement | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 12, 2024 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 12, 2024 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 12, 2024 |
| 3 | Initial insider ownership | Jan 29, 2024 | Jan 26, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 26, 2024 | Jan 23, 2024 |
| 8-K |
Current report
Listing notice
|
Jan 19, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| D | Filing | Dec 26, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Dec 26, 2023 | Dec 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 20, 2023 | Dec 20, 2023 |
| 8-K |
Current report
Auditor change
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 1, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 16, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2023 | Sep 11, 2023 |
| 424B5 | Prospectus supplement | Aug 30, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Aug 30, 2023 | Aug 29, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Auditor change
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 21, 2023 | Jul 19, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Jul 5, 2023 | Jul 4, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2023 | Jun 21, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 21, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 21, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 21, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 21, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 21, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 21, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 5, 2023 | Jun 5, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| ARS | Annual report to shareholders | May 1, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | Jun 21, 2023 |
| 424B5 | Prospectus supplement | Mar 31, 2023 | — |
| 8-K |
Current report
Material agreement
|
Mar 31, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Other events
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Other events
|
Feb 6, 2023 | Feb 6, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 27, 2023 | Jan 24, 2023 |
| 4 | Insider transaction | Jan 26, 2023 | Jan 24, 2023 |
| 4 | Insider transaction | Jan 26, 2023 | Jan 24, 2023 |
| 4 | Insider transaction | Jan 26, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Other events
|
Jan 25, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 16, 2022 | Dec 16, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 12, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Other events
|
Dec 5, 2022 | Dec 1, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 14, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DARE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1401914
- Former names
- Cerulean Pharma Inc. (until Jul 5, 2017); Tempo Pharmaceuticals Inc (until Jan 22, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.